Ergebnis der Suchanfrage nach celle
Inhalte
- Kategorie:
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- 2Ein Dokumentmehr
- 3
World Cancer Day: Start-ups at the IZB develop innovative cancer drugs and diagnostic tools
Ein Dokumentmehr MAHLE successfully completes Keihin acquisition
MAHLE successfully completes Keihin acquisition - Takeover of Keihin’s air conditioning business on February 1, 2021 - Approval by the antitrust authorities - Acquisition of five locations in Asia and North America - Strengthening of MAHLE’s position in the important future field of air conditioning With effect from February 1, 2021, MAHLE has taken over the air conditioning business in Japan, Thailand, and the USA ...
mehrDeutsche Leibrenten Grundbesitz AG
Pension fund finances continued growth of Deutsche Leibrenten AG / Convertible bonds increased from 50 to 75 million euro
Frankfurt (ots) - Deutsche Leibrenten Grundbesitz AG is funding its strong growth with the support of noted German institutional investors. The amount of convertible bonds issued in November 2019, a total of 50 million euro, has been increased by a further 25 million euro. This activity provides the market leader in ...
mehrEleva Secures up to EUR 60 million to Advance a Drug Candidate, Appoints New Board Member
Freiburg (ots) - Eleva, a manufacturer of superior biologics, has secured up to EUR 60 million in funding from Zukunftsfonds Heilbronn (ZFHN). The funds will help advance one of its drug candidates, CPV-101, to stages that will facilitate further investment from venture capitalists and/or pharmaceutical companies. Eleva also announced the addition of Dr. Ralf Smit to ...
mehrTechnische Universität München
Supercapacitors challenge batteries: graphene hybrid material reaches power density of batteries
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center Phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36404/ High resolution images: https://mediatum.ub.tum.de/1586305 NEWS RELEASE Supercapacitors ...
mehrTechnische Universität München
Artificial intelligence improves accuracy: self-learning algorithms analyze medical imaging data
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center Phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36399/ High resolution images: https://mediatum.ub.tum.de/1585829 NEWS RELEASE Quick look under the skin Self-learning algorithms analyze medical imaging ...
mehrSysmex Inostics Presents Data at the American Society of Hematology Annual Meeting Demonstrating Exquisite Sensitivity of SafeSEQ NGS Technology for Detection of Measurable Residual Disease in Acute Myeloid Leukemia
Baltimore, MD (ots) - Sysmex Inostics, Inc., a global leader and pioneer in blood-based, high-sensitivity molecular testing for oncology, is presenting the poster "Ultrasensitive Measurable Residual Disease (MRD) Detection in Acute Myeloid Leukemia (AML) Using a Targeted Next Generation Sequencing (NGS) Panel" at ...
mehrTechnische Universität München
On the trail of the genetic code - Overlapping gene found in SARS-CoV-2
Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36345/ NEWS RELEASE On the trail of the genetic code Overlapping gene found in SARS-CoV-2 Viruses are infectious organic structures that spread by transmission and can only multiply within a ...
mehr- 3
Press release | MAHLE-keeping the world moving for 100 years
mehr Press release | MAHLE to sell shares in MAHLE König
MAHLE to sell shares in MAHLE König - With effect from the end of November 2020, all of MAHLE’s shares will be transferred to the König founding family - MAHLE has held a 50 percent shareholding in MAHLE König since 1999 - MAHLE shares held as a financial participation in recent years - MAHLE König specializes in high-performance engines for recreational, motorcycle, and industrial applications With effect from the ...
mehrTechnische Universität München
Neutrons detect air pollution - Looking for clues with the Prompt Gamma Activation Analysis method
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36327/ High resolution images: https://mediatum.ub.tum.de/1579295 NEWS RELEASE Neutrons detect air pollution Looking for clues with the Prompt Gamma ...
mehrSwiss Rockets AG announces the founding of ROCKETVAX for the development of a next-generation SARS-CoV-2 vaccine
mehrTechnische Universität München
Immune response: memory T cells are formed earlier than previously thought
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22562 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36297/ NEWS RELEASE How the immune system remembers viruses Immune response: memory T cells are formed earlier than previously thought For a person to ...
mehrEvoBiotiX collaborates with Boehringer Ingelheim and the University of Salzburg on naturally derived Extracellular Vesicles (EVs)
Salzburg/Melide(CH) (ots) - Swiss Biotech EvoBiotiX SA today announced a multi-year collaboration with Boehringer Ingelheim in the field of naturally derived EVs. A significant part of this program will fund research of the drug delivery potential of naturally derived EVs in the group of Prof. Meisner-Kober at the ...
mehrTechnische Universität München
eGovernment MONITOR: Use of e-government in the German speaking region continues to increase
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36260/ NEWS RELEASE New edition of the eGovernment MONITOR Digital administration: Corona is not ...
mehr- 2
Proteintech Acquires ChromoTek, Expanding its Next Generation Antibody Tools
Ein Dokumentmehr Technische Universität München
Coronavirus: door opener facilates cell entry
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22562 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36263/ NEWS RELEASE How the virus enters the cell Coronavirus: Neuropilin-1 could open the door to the inside of the cell The protein neuropilin-1 facilitates SARS CoV-2 cell entry. A research team including ...
mehr- 3
MAHLE to push ahead with future technologies
mehr Technische Universität München
Fighting corona with machine learning
Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36254/ NEWS RELEASE The Bavarian Research Foundation is funding five TUM-research projects on Covid-19 Fighting corona with machine learning The Technical University of Munich (TUM) is starting five new research projects that focus on the ...
mehrTechnische Universität München
An alternative to animal experiments - New applications for organoids from human intestinal tissue
Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36252/ Images for journalists: https://mediatum.ub.tum.de/1576619 NEWS RELEASE New applications for organoids from human intestinal ...
mehr- 3
MAHLE sets up global development center for mechatronics in Kornwestheim
mehr Regulatory breakthrough for BrainRepair UG start-up - Stem cell treatment for newborns /EMA Orphan Drug Designation is followed by agreement on Paediatric Investigation Plan
mehrTechnische Universität München
Intelligent software for a better understanding of plant tissue development
Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36238/ Images for journalists: https://mediatum.ub.tum.de/1575701 NEWS RELEASE Intelligent software for a better understanding of plant tissue development 3D images display plant organs down ...
mehr- 4
"Honey, I shrunk the detector": Researchers have developed the world's smallest ultrasound detector
mehr MAHLE accelerates restructuring of Group
- Challenging market environment and technological transformation: expansion of MAHLE's ongoing cost-saving and restructuring programs - Coronavirus crisis intensifies urgency to act-no return to precrisis levels expected for several years - Further capacity and structural adjustments required: excess global capacities of 7,600 jobs - Despite economic pressures, focus remains on technological transformation and strategic ...
mehr- 3
MAHLE opens Start-Up Space for new business ideas
mehr Sysmex Inostics' Liquid Biopsy Testing Benefits Metastatic Pancreatic Cancer Patient Management
Baltimore, MD (ots) - Sysmex Inostics, Inc., a global leader and pioneer in blood-based circulating cell-free tumor DNA (ctDNA) analysis for oncology, today announces the publication of a clinical study investigating the utility of cfDNA-based markers using the highly sensitive OncoBEAM RAS assay, an enhanced ...
mehrTechnische Universität München
Finding cortisone alternatives with fewer side effects
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/die-tum/aktuelles/pressemitteilungen/details/36207/ Images for journalists: https://mediatum.ub.tum.de/1559845 NEWS RELEASE DNA binding is essential for effectiveness of steroids Finding cortisone alternatives with fewer side effects Many people use ...
mehrSysmex Inostics' OncoBEAMTM RAS CRC testing supports clinical outcome improvements for metastatic colorectal cancer patients rechallenged with anti-EGFR therapy
Baltimore, MD (ots) - Sysmex Inostics, Inc., a global leader and pioneer in blood-based circulating tumor DNA (ctDNA) analysis for oncology, today announces the publication of a clinical study evaluating RAS mutation status in circulating tumor DNA (ctDNA) of colorectal cancer (CRC) patients undergoing anti-EGFR ...
mehr